Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Daugaard

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Cancer Treatment Reviews|April 1, 1994
Unknown primary tumoursG Daugaard
Danish Medical Bulletin|February 1, 1990
Cisplatin nephrotoxicity: experimental and clinical studiesG Daugaard
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1993
Tamoxifen and hypercalcaemiaG Daugaard
Cancer Chemotherapy and Pharmacology|January 1, 1989
Cisplatin nephrotoxicity. A reviewG Daugaard, U Abildgaard
Critical Reviews in Oncology/Hematology|November 1, 1992
Evaluation of nephrotoxicity secondary to cytostatic agentsG Daugaard, U Abildgaard
European Journal of Cancer & Clinical Oncology|April 1, 1986
High-dose cisplatin and VP-16 with bleomycin, in the management of advanced metastatic germ cell tumorsG Daugaard, M Rŗth
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1992
Treatment of poor-risk germ-cell tumors with high-dose cisplatin and etoposide combined with bleomycinG Daugaard, M Rørth
Cancer Treatment Reviews|April 23, 1999
Cisplatin and hypomagnesemiaH Lajer, G Daugaard
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Management of carcinoma of unknown primary site (CUP), any changes?H H Hansen, G Daugaard
Ugeskrift for Laeger|October 27, 1997
[Prognostic factors in patients with disseminated germ cell tumors]K G Daugaard, H H Hansen
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Cancer Treatment Reviews|April 1, 1994
Unknown primary tumoursG Daugaard
Danish Medical Bulletin|February 1, 1990
Cisplatin nephrotoxicity: experimental and clinical studiesG Daugaard
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1993
Tamoxifen and hypercalcaemiaG Daugaard
Cancer Chemotherapy and Pharmacology|January 1, 1989
Cisplatin nephrotoxicity. A reviewG Daugaard, U Abildgaard
Critical Reviews in Oncology/Hematology|November 1, 1992
Evaluation of nephrotoxicity secondary to cytostatic agentsG Daugaard, U Abildgaard
European Journal of Cancer & Clinical Oncology|April 1, 1986
High-dose cisplatin and VP-16 with bleomycin, in the management of advanced metastatic germ cell tumorsG Daugaard, M Rŗth
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1992
Treatment of poor-risk germ-cell tumors with high-dose cisplatin and etoposide combined with bleomycinG Daugaard, M Rørth
Cancer Treatment Reviews|April 23, 1999
Cisplatin and hypomagnesemiaH Lajer, G Daugaard
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Management of carcinoma of unknown primary site (CUP), any changes?H H Hansen, G Daugaard
Ugeskrift for Laeger|October 27, 1997
[Prognostic factors in patients with disseminated germ cell tumors]K G Daugaard, H H Hansen
Pageof 10